Patent · US Active

4,6-disubstitued pyrimidines useful as kinase inhibitors

US8329901B2 · kind B2 · utility

11Cited by

9References

5Claims

0Family size

Assignee

Celgene Avilomics Research, Inc. · US

Inventors

Juswinder Singh · Southborough, US
Shomir Ghosh · Brookline, US
Arthur F. Kluge · Lincoln, US
Russell C. Petter · Stow, US
Richland Wayne Tester · Marlborough, US

Key dates

Filing date	Feb 1, 2011
Grant date	Dec 11, 2012
Priority date	—
Expiry date	Feb 1, 2031

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02P20/582
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention provides 4,6-disubstituted pyrimidine compound useful as kinase inhibitors, pharmaceutically acceptable compositions thereof, and methods of using the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.